Phenotype | Mechanism of action | Species | References |
---|---|---|---|
Nervous system | |||
Aggression | MSY | Human | |
Mainly MSY acting through increased testosterone | Mouse | ||
MSY acting through increased tesosterone and decreased serotonin | Rat | [29] | |
Alcoholism | Y chromosome haplogroups | Human | [30] |
Alzheimer’s disease | LOY | Human | |
Anxiety | Chromosome Y consomic strains (also imprinting the daughter’s genome, thus decreasing anxiety) | Mouse | |
Autism | Extra Y or variation in it (SRY and NLGN4Y in particular) | Human | |
Sry in interaction with the genetic background on β-endorphin levels | Mouse | [38] | |
Chemosensory system | MSY (chromosome Y consomic strains) | Mouse | |
Dopamine system | SRY increases catecholamine synthesis and metabolism | Human | [41] |
MSY through tesosterone in hippocampus | Mouse | ||
Chromosome Y consomic strains (Sry1) | Rat | [45] | |
Hearing impairment | DFNA49 insertion from chromosome 1 | Human | [46] |
Intelligence | Reduction due to extra Y, p.I679V NLGN4Y | Human | |
Macrocephaly and brain size | Y chromosome increases size | Human | |
Motor functioning | Larger or extra Y as well as SRY through regulation of monoamine oxidase A | Human | |
Possibly through Sry | Rat | [50] | |
Norepinephrine concentration | Possibly through Sry | Rat | |
Parkinson’s disease | SRY as a risk factor | Human and rat | [52] |
Response acquisition | Y epistatically interacts with autosome 9 | Mouse | [42] |
Schizophrenia | LOY | Human | |
Stress | Y, possibly through Sry, interacts with other chromosomes | Rat | |
Suicide | LOY in blood | Human | [56] |
Cardiovascular and immune system | |||
Atherosclerosis | MSY (mainly lower expression of UTY and Lnc-KDM5D-4) | Human | |
Cardiomyocyte size | Due to different responses to testosterone | Mouse | |
Coronary artery disease | MSY (mainly lower expression of UTY) | Human | |
Hypertension | Protective role through increased expression of BMPR2 via SRY | Human | [64] |
Y has a protective role | Mouse | ||
Through Sry affecting several renin-angiotensin and SNS gene promoter activity | Rat | ||
Lipid profile | Y haplotypes (possible gene - lnc-KDM5D-4) | Human | |
Chromosome Y consomic strains | Mouse | [74] | |
Chromosome Y consomic strains | Rat | ||
Na and insulin levels | Chromosome Y consomic strains (Sry3) | Rat | [77] |
Autoimmunity | LOY in blood | Human | |
Copy number variation of Sly and Rbmy and gain of telomeric end of the X | Mouse | ||
Immune cell abnormalities | Independent of Sry and IFN-αβ | Mouse | |
Loss of CD99 on the PAR | Human | [91] | |
Viral infections | Haplogroup I | Human | HIV-1 [92] |
Chromosome Y consomic strains (independent of Sry) | Mouse | ||
Other traits | |||
Albuminuria | Chromosome Y consomic strains | Rat | [95] |
Cancer | LOY, aneuploidy, misexpression of MSY genes in somatic cells, microdeletions | Human | |
Loss of UTY | Mouse | [101] | |
Sry as an oncogene | Rat | [102] | |
Baldness | SRY in the scalp | Human | [103] |
Body size | MSY increases height independently of sex hormones | Human | |
Y epistatically interacts with autosome 9 independently of Sry | Mouse | ||
Diabetes | LOY | Human | [78] |
Glucose metabolism | Y interacts with chromosome 2 | Rat | [76] |
Hirschsprung disease | SRY represses RET | Human | [110] |
Hypertelorism | Extra Y | Human | [48] |
Liver damage | LOY | Human | [96] |
Macular degeneration | LOY in blood | Human | [111] |
Mortality | Extra Y and LOY in blood decreases lifespan, while hypermethylation of Y has a protective mechanism | Human and other mammals | |
Sensitivity to testosterone | MSY | Mouse | |
Tooth growth | Genes on the Yqll promote | Human | [116] |